82 related articles for article (PubMed ID: 16443173)
1. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
2. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
3. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
[TBL] [Abstract][Full Text] [Related]
4. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
6. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
7. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function.
Paulsen SJ; Vrang N; Larsen LK; Larsen PJ; Jelsing J
J Anat; 2010 Nov; 217(5):624-30. PubMed ID: 20807269
[TBL] [Abstract][Full Text] [Related]
8. Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals.
Wang X; DuBois DC; Sukumaran S; Ayyar V; Jusko WJ; Almon RR
Diabetes Metab Syndr Obes; 2014; 7():531-41. PubMed ID: 25419150
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats.
Chayah M; Luque-González A; Gómez-Pérez V; Salagre D; Al-Shdaifat A; Campos JM; Conejo-García A; Agil A
Drug Des Devel Ther; 2024; 18():1133-1141. PubMed ID: 38618281
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme A and Its Thioester Pools in Obese Zucker and Zucker Diabetic Fatty Rats.
Chohnan S; Matsuno S; Shimizu K; Tokutake Y; Kohari D; Toyoda A
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32041091
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of interferon tau enhances oxidation of energy substrates and reduces adiposity in Zucker diabetic fatty rats.
Tekwe CD; Lei J; Yao K; Rezaei R; Li X; Dahanayaka S; Carroll RJ; Meininger CJ; Bazer FW; Wu G
Biofactors; 2013; 39(5):552-63. PubMed ID: 23804503
[TBL] [Abstract][Full Text] [Related]
12. A Novel Rat Model of Type 2 Diabetes: The Zucker Fatty Diabetes Mellitus ZFDM Rat.
Yokoi N; Hoshino M; Hidaka S; Yoshida E; Beppu M; Hoshikawa R; Sudo K; Kawada A; Takagi S; Seino S
J Diabetes Res; 2013; 2013():103731. PubMed ID: 23671847
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
Pickavance LC; Widdowson PS; Foster JR; Williams G; Wilding JP
Int J Exp Pathol; 2003 Apr; 84(2):83-9. PubMed ID: 12801282
[TBL] [Abstract][Full Text] [Related]
14. Disrupted circadian rhythmicity of the intestinal glucose transporter SGLT1 in Zucker diabetic fatty rats.
Bhutta HY; Deelman TE; Ashley SW; Rhoads DB; Tavakkoli A
Dig Dis Sci; 2013 Jun; 58(6):1537-45. PubMed ID: 23633155
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat.
Stabley JN; Prisby RD; Behnke BJ; Delp MD
J Endocrinol; 2015 Apr; 225(1):47-58. PubMed ID: 25817711
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.
Sárközy M; Zvara A; Gyémánt N; Fekete V; Kocsis GF; Pipis J; Szűcs G; Csonka C; Puskás LG; Ferdinandy P; Csont T
Cardiovasc Diabetol; 2013 Jan; 12():16. PubMed ID: 23320804
[TBL] [Abstract][Full Text] [Related]
17. Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats.
Szabó K; Énzsöly A; Dékány B; Szabó A; Hajdú RI; Radovits T; Mátyás C; Oláh A; Laurik LK; Somfai GM; Merkely B; Szél Á; Lukáts Á
Sci Rep; 2017 Aug; 7(1):8891. PubMed ID: 28827737
[TBL] [Abstract][Full Text] [Related]
18. Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes.
Johnson LE; Larsen M; Perez MT
PLoS One; 2013; 8(2):e55456. PubMed ID: 23408985
[TBL] [Abstract][Full Text] [Related]
19. Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats.
Paniagua N; Girón R; Goicoechea C; López-Miranda V; Vela JM; Merlos M; Martín Fontelles MI
Eur J Pain; 2017 Jan; 21(1):61-72. PubMed ID: 27341510
[TBL] [Abstract][Full Text] [Related]
20. Bee Bread Can Alleviate Lipid Abnormalities and Impaired Bone Morphology in Obese Zucker Diabetic Rats.
Martiniakova M; Blahova J; Kovacova V; Babikova M; Mondockova V; Kalafova A; Capcarova M; Omelka R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33947088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
